163.79
1.36%
+2.20
Handel nachbörslich:
163.89
0.10
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Pfizer: Best Trading Momentum Since 2021 And 6% Yield
Seeking Alpha
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Benzinga
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks Investment Research
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks Investment Research
3 Magnificent Stocks That Are Passive Income Machines
The Motley Fool
What Is the Dividend Payout for AbbVie Stock?
The Motley Fool
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Zacks Investment Research
My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
Seeking Alpha
Earn $1000 Every Month From These 3 Stocks
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
The Motley Fool
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks Investment Research
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
The Motley Fool
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks Investment Research
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks Investment Research
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
Zacks Investment Research
3 Reasons to Buy AbbVie Stock on the Dip
The Motley Fool
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks Investment Research
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Zacks Investment Research
Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?
Zacks Investment Research
AbbVie (ABBV) Could Be a Great Choice
Zacks Investment Research
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks Investment Research
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Benzinga
Better Dividend Stock: AbbVie or Johnson & Johnson?
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
The Motley Fool
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
The Motley Fool
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
The Motley Fool
Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
Benzinga
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks Investment Research
PCE/Core PCE Numbers Came In Line With Expectations
Zacks Investment Research
PCE In-Line to Warmer, Pre-Market Calms; ABBV Beats, XOM Misses
Zacks Investment Research
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
Benzinga
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
Zacks Investment Research
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks Investment Research
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Zacks Investment Research
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks Investment Research
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks Investment Research
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks Investment Research
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks Investment Research
Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably
Seeking Alpha
Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
Zacks Investment Research
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
Buying the Dip in These 3 Undervalued Dividend Stocks
The Motley Fool
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Zacks Investment Research
Is Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?
Zacks Investment Research
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Benzinga
Kapitalisierung:
|
Volumen (24h):